Portfolio company
SonoClear
Norway · £45.0m raised
Raised
£45.0m
Latest stage
Growth
Rounds recorded
1
Backed by
1 investor
Sectors
About
SonoClear produces an acoustic coupling fluid and transfer kit to improve intraoperative ultrasound image clarity for neurosurgeons performing brain tumour resections.
SourceFunding history · 1
Similar companies
Nisonic
Nisonic develops ultrasound software and transducers for non-invasive intracranial pressure assessment, serving neurosurgeons and clinical researchers treating patients with brain injuries.
Clee Medical
The company develops an intraoperative imaging and navigation platform for neurosurgeons to perform minimally invasive brain surgery with real-time tissue and vasculature visualization.
Carthera
This company develops an ultrasound-based medical device to increase the permeability of the blood-brain barrier for patients with tumours and neurodegenerative diseases.
Cordance Medical
This company develops a focused ultrasound device to open the blood-brain barrier for clinicians treating patients with brain tumours and other neurological diseases.
EnClear Therapies
The company develops a drug delivery system for the cerebrospinal fluid to treat patients with neurological diseases and brain tumours.
Neurolase
This company develops a handheld laser device using artificial intelligence to help neurosurgeons identify cancerous brain tissue in real time during surgery.
Agitated Solutions
Agitated Solutions develops ultrasound contrast agents and microbubble generators for clinical sonographers to improve image quality and diagnostic efficiency during cardiac studies.
Nisonic AS
Nisonic AS develops ultrasound software and imaging devices for the non-invasive measurement of intracranial pressure in patients with neurological conditions and brain injuries.
